Viewing data from:

LOPERAMIDE HYDROCHLORIDE

ANDA

LOPERAMIDE HYDROCHLORIDE | A075232 | L PERRIGO CO

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 12 NDCs

Highest NADAC/Unit

$0.1319

per ea

Lowest NADAC/Unit

$0.1319

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00113222462ANTI-DIARRHEAL 2 MG CAPLET	$0.1319	EA	Generic	—	2026-06-17
00113222468ANTI-DIARRHEAL 2 MG CAPLET	$0.1319	EA	Generic	—	2026-06-17
24385055453ANTI-DIARRHEAL 2 MG CAPLET	$0.1319	EA	Generic	—	2026-06-17
24385055462ANTI-DIARRHEAL 2 MG CAPLET	$0.1319	EA	Generic	—	2026-06-17
00113022453GS ANTI-DIARRHEAL 2 MG CAPLET	$0.1319	EA	Generic	—	2026-06-17
00113022462GS ANTI-DIARRHEAL 2 MG CAPLET	$0.1319	EA	Generic	—	2026-06-17

Showing 6 of 12 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$0.97

Highest Price

$2.05

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00113-0224-53LOPERAMIDE HCL 2MG TAB	$0.97	FSS	Golden State Medical Supply, Inc.	06/14/2028
00113-0224-62LOPERAMIDE HCL 2MG TAB	$1.05	FSS	Golden State Medical Supply, Inc.	06/14/2028
00904-7725-12ANTI-DIARRHEAL 2MG CAPLET	$1.25	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7725-24ANTI-DIARRHEAL 2MG CAPLET	$2.05	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain6 active DMFs4 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVLOPERAMIDE HYDROCHLORIDE

DMF 73401988

PMC ISOCHEMLOPERAMIDE HYDROCHLORIDE

DMF 74531988

OLON SPALOPERAMIDE HYDROCHLORIDE

DMF 100281992

OLON SPALOPERAMIDE HYDROCHLORIDE

DMF 105171993

VASUDHA PHARMA CHEM LTDLOPERAMIDE HYDROCHLORIDE USP

DMF 277312013

VAMSI LABS LTDLOPERAMIDE HYDROCHLORIDE USP

DMF 425912025

SIFAVITOR SPAInactiveLOPERAMIDE HYDROCHLORIDE

DMF 72991988

SIPSY CHIMIE FINE SCAInactiveLOPERAMIDE HYDROCHLORIDE

DMF 80511989

LANZ LABORATORIESInactiveLOPERAMIDE HYDROCHLORIDE

DMF 83141989

JANSSEN PHARMACEUTICA NVInactiveLOPERAMIDE HYDROCHLORIDE

DMF 109421994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 6, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 2MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jan 6, 2000

No patent or exclusivity listings for this strength.